Real-world Data from KRAS-mutant Advanced NSCLC: the ATLAS Multicenter Cohort Study

被引:0
|
作者
Bungaro, M. [1 ]
Garbo, E. [1 ]
Jacobs, F. [1 ]
Reale, M. L. [1 ]
Passiglia, F. [1 ]
Tiseo, M. [2 ]
Genova, C. [3 ]
Galetta, D. [4 ]
Malapelle, U. [5 ]
Troncone, G.
Novello, S. [1 ,5 ]
机构
[1] Univ Turin, San Luigi Gonzaga Hosp, Turin, Italy
[2] Univ Parma, Med Oncol Unit, Parma, Italy
[3] IRCCS Osped San Martino, Genoa, Italy
[4] IRCCS Ist Tumori Giovanni Paolo II, Bari, Italy
[5] Univ Naples Federico II, Naples, Italy
关键词
Real-world data; NSCLC; KRAS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP08.02-10
引用
收藏
页码:S449 / S449
页数:1
相关论文
共 50 条
  • [21] Paclitaxel Liposome Combined with Immunotherapy in the First-Line Treatment of Advanced NSCLC: A Multicenter Real-World Study
    Jiang, L.
    Zheng, D.
    Ni, J.
    Ding, H.
    Zhao, Y.
    Heng, W.
    Shang, Y.
    Cai, X.
    Yan, J.
    Wang, J.
    Guo, J.
    Tan, X.
    Hong, X.
    Zhang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S248 - S249
  • [22] Signaling Networks in KRAS-Mutant Advanced NSCLC: A Complex Landscape Involving Immunoresponse, Inflammation and DNA Repair
    Baglivo, Sara
    Baldelli, Elisa
    Crino, Lucio
    Ludovini, Vienna
    Chiari, Rita
    Metro, Giulio
    Bennati, Chiara
    Hodge, Alex
    Siggillino, Annamaria
    Tofanetti, Francesca Romana
    Dong, Ting
    Pistola, Lorenza
    Bianconi, Fortunato
    Sidoni, Angelo
    Minotti, Vincenzo
    Petricoin, Emanuel
    Pierobon, Mariaelena
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S360 - S361
  • [23] Real-world routine KRAS testing practices in France for patients (pts) with advanced or metastatic (AM) non-small cell lung cancer (NSCLC): Data from the ESME cohort
    Valette, C. Audigier
    Perol, M.
    Girard, N.
    Bosquet, L.
    De Gunten, L.
    Desamericq, G.
    Tzala, L.
    Allard, B.
    Debieuvre, D.
    ANNALS OF ONCOLOGY, 2023, 34
  • [24] Real-world Experience of the Utility in Afatinib Therapy for Patients with EGFR-Mutant Advanced NSCLC
    Igawa, S.
    Ono, T.
    Kasajima, M.
    Yamada, K.
    Oguri, A.
    Kameda, A.
    Yamamoto, H.
    Kakegawa, M.
    Hiyoshi, Y.
    Kusuhara, S.
    Ozawa, T.
    Otani, S.
    Fukui, T.
    Mitsufuji, H.
    Masaru, K.
    Yokoba, M.
    Kubota, M.
    Sasaki, J.
    Naoki, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S611 - S611
  • [25] Real-World treatment outcomes for advanced NSCLC in Greece
    Kokkotou, Eleni
    Stournara, Lamprini
    Mani, Maria
    Gkiozos, Ioannis
    Tsagouli, Sofia
    Syrigos, Nikolaos
    Burke, Thomas
    Desiniotis, Andreas
    Dimitriadis, Ioannis
    Charpidou, Andriani
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [26] Sotorasib in KRAS G12C-mutated NSCLC: A multicenter real-world experience from the expanded access program in Germany
    Althoff, F. C.
    Stratmann, J. A.
    Doebel, P.
    Hunerlituerkoglu, A. N.
    Frost, N.
    Christopoulos, P.
    Zum Bueschenfelde, C. Meyer
    Alt, J.
    Webendoerfer, M.
    Kaldune, S.
    Tritchkova, G.
    Waller, C. F.
    Braess, J.
    Kopp, H-G.
    Grohe, C.
    Schumann, C.
    Griesinger, F.
    Kuon, J. B.
    Sebastian, M.
    Reinmuth, N.
    ANNALS OF ONCOLOGY, 2023, 34
  • [27] PD-1 targeted immunotherapy in advanced hepatocellular carcinoma: Efficacy and safety data from an international multicenter real-world cohort
    Scheiner, Bernhard
    Kirstein, Martha
    Hucke, Florian
    Finkelmeier, Fabian
    Schulze, Kornelius
    von Felden, Johann
    Koch, Sandra
    Schwabl, Philipp
    Hinrichs, Jan
    Waidmann, Oliver
    Reiberger, Thomas
    Mueller, Christian
    Sieghart, Wolfgang
    Trauner, Michael
    Weinmann, Arndt
    Wege, Henning
    Trojan, Joerg
    Peck, Markus
    Vogel, Arndt
    Pinter, Matthias
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E88 - E89
  • [28] Profile of Patients with NSCLC Who Benefit from Immunochemotherapy. Real-World Data from the Multicenter Polish Lung Cancer Group Study
    Knetki-Wroblewska, M.
    Krawczyk, P.
    Bryl, M.
    Jankowski, T.
    Milanowski, J.
    Wrona, A.
    Bandura, A.
    Dziadziuszko, R.
    Smok-Kalwat, J.
    Rok-Knapinska, J.
    Szydziak-Zwierzynska, K.
    Rogoziewicz, K.
    Stencel, K.
    Zewicz, G. Czy
    Wojtowicz, M.
    Wojtukiewicz, M.
    Kalinka, E.
    Wysocki, P.
    Lobacz, M.
    Pawlik, H.
    Kowalski, D. M.
    Krzakowski, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S623 - S623
  • [29] Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study
    Shinsuke Muraoka
    Takumi Asai
    Takahiko Fukui
    Shinji Ota
    Shinji Shimato
    Naoki Koketsu
    Toshihisa Nishizawa
    Yoshio Araki
    Ryuta Saito
    Neurosurgical Review, 46
  • [30] Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study
    Muraoka, Shinsuke
    Asai, Takumi
    Fukui, Takahiko
    Ota, Shinji
    Shimato, Shinji
    Koketsu, Naoki
    Nishizawa, Toshihisa
    Araki, Yoshio
    Saito, Ryuta
    NEUROSURGICAL REVIEW, 2023, 46 (01)